Marijuana Use, Respiratory Symptoms, and Pulmonary Function: A Systematic Review and Meta-analysis
- PMID: 29971337
- PMCID: PMC6231497
- DOI: 10.7326/M18-0522
Marijuana Use, Respiratory Symptoms, and Pulmonary Function: A Systematic Review and Meta-analysis
Abstract
Background: The health effects of smoking marijuana are not well-understood.
Purpose: To examine the association between marijuana use and respiratory symptoms, pulmonary function, and obstructive lung disease among adolescents and adults.
Data sources: PubMed, Embase, PsycINFO, MEDLINE, and the Cochrane Library from 1 January 1973 to 30 April 2018.
Study selection: Observational and interventional studies published in English that reported pulmonary outcomes of adolescents and adults who used marijuana.
Data extraction: Four reviewers independently extracted study characteristics and assessed risk of bias. Three reviewers assessed strength of evidence. Studies of similar design with low or moderate risk of bias and sufficient data were pooled.
Data synthesis: Twenty-two studies were included. A pooled analysis of 2 prospective studies showed that marijuana use was associated with an increased risk for cough (risk ratio [RR], 2.04 [95% CI, 1.02 to 4.06]) and sputum production (RR, 3.84 [CI, 1.62 to 9.07]). Pooled analysis of cross-sectional studies (1 low and 3 moderate risk of bias) showed that marijuana use was associated with cough (RR, 4.37 [CI, 1.71 to 11.19]), sputum production (RR, 3.40 [CI, 1.99 to 5.79]), wheezing (RR, 2.83 [CI, 1.89 to 4.23]), and dyspnea (RR, 1.56 [CI, 1.33 to 1.83]). Data on pulmonary function and obstructive lung disease were insufficient.
Limitation: Few studies were at low risk of bias, marijuana exposure was limited in the population studied, cohorts were young overall, assessment of marijuana exposure was not uniform, and study designs varied.
Conclusion: Low-strength evidence suggests that smoking marijuana is associated with cough, sputum production, and wheezing. Evidence on the association between marijuana use and obstructive lung disease and pulmonary function is insufficient.
Primary funding source: None. (PROSPERO: CRD42017059224).
Conflict of interest statement
Figures
Comment in
-
Marijuana Use, Respiratory Symptoms, and Pulmonary Function.Ann Intern Med. 2019 Jan 15;170(2):142. doi: 10.7326/L18-0614. Ann Intern Med. 2019. PMID: 30641566 No abstract available.
References
-
- Prevalence of marijuana use among U.S. adults doubles over past decade [press release]. Bethesda: National Institutes of Health; 21 October 2015.
-
- National Institutes of Health. NIH's 2017 Monitoring the Future survey shows both vaping and marijuana are more popular than traditional cigarettes or pain reliever misuse. 2017. Accessed at www.drugabuse.gov/related-topics/trends-statistics/monitoring-future on 14 December 2017.
-
- Hoffmann D, Brunnemann KD, Gori GB, Winder EL. On the carcinogenicity of marijuana smoke In: Runeckles VC, ed. Recent Advances in Phytochemistry. Boston: Springer-Verlag; 1975:63–81.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous